Quoted Micro 8 September 2025
AQUIS STOCK EXCHANGE AI technology developer Astrid Intelligence (ASTR) moved from the Main Market to the Access segment of Aquis on 3 September. The company was previously a CBD and health products retailer known as Cellular Goods and most recently it was called Cel AI. It is developing autonomous AI agents that provide personalised wellness […]
Quoted Micro 12 May 2025
AQUIS STOCK EXCHANGE In 2024, Newbury Racecourse (NYR) increased revenues by 16% to £22m and pre-tax profit improved from £720,000 to £1.1m. There were 30 race days, two more than the previous year. A final dividend of 6p/share was announced. Cash was £7.5m at the end of 2024. Recent Acquis new entrant Smarter Web Company […]
Quoted Micro 17 March 2025
AQUIS STOCK EXCHANGE All Things Considered (ATC) has raised its stake in Brighton venture Concorde 2 to 80% and acquired the remaining shares in bar services provider JTR Productions for £2.49m and 60% of Brighton venue Volks, which is close to Concorde 2, for £400,000. This broadens the range of music-related services that can be […]
Quoted Micro 23 December 2024
AQUIS STOCK EXCHANGE Surgical procedures provider One Health Group (OHGR) increased revenues 22% to £13.3m, while pre-tax profit improved from £560,000 to £845,000. The interim dividend was raised 2% to 2.07p/share. Cash in the bank was £4.89m at the end of September 2024. There have been record referrals by the NHS since the end of […]
Alan Green covers pre IPO company SpectrumX and Audioboom #BOOM on this week’s Stockbox Research Talks
Alan Green covers the pre IPO investment opportunity at SpectrumX and Audioboom #BOOM on this week’s Stockbox Research Talks.
Quoted Micro 28 February 2022
AQUIS STOCK EXCHANGE Good Energy (GOOD) has finalised the sale price of its electricity generation assets. There was deferred consideration of up to £8.1m. The deferred payment has been set at £4.8m, taking the total payment to £21.2m. The rest of the cash was not paid due to a third-party yield assessment and other due […]
Alan Green talks Synairgen #SNG, Destiny Pharma #DEST & Mode Group #MODE on Vox Markets podcast
Alan Green discusses Synairgen #SNG, Destiny Pharma #DEST & Mode Group #MODE with Justin Waite on the Vox Markets podcast. Interview is 12 minutes 40 seconds in.
Alan Green talks Synairgen #SNG, OnTheMarket #OTMP, ECR Minerals #ECR & Blencowe Resources #BRES on the Vox Markets podcast
Alan Green discusses Synairgen #SNG, OnTheMarket #OTMP, ECR Minerals #ECR & Blencowe Resources #BRES with Justin Waite on the Vox Markets podcast. Interview is 14 minutes in.
Alan Green presents the investment case for Synairgen #SNG, Omega Diagnostics #ODX, Open Orphan #ORPH & Venture Life #VLG on his weekly Stockbox Media Research talk
Alan Green presents the investment case for Synairgen #SNG, Omega Diagnostics #ODX, Open Orphan #ORPH & Venture Life #VLG on his weekly Stockbox Media Research talk.
Alan Green talks COVID stocks Novacyt #NCYT), Synairgen #SNG, Avacta #AVCT, plus Blue Prism #PRSM & Capita #CPI on the UK Investor Magazine podcast
The UK Investor Magazine Podcast is joined by Alan Green for a run down of the dramatic moves in markets this week and exploration of scenarios going into the end of 2020. The Biden Presidential victory has been overshadowed by news from Pfizer had a breakthrough in the fight against COVID-19 with a vaccine demonstrating […]